We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-1.06%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$481B
AUM Growth
+$34.6B
Cap. Flow
+$38.1B
Cap. Flow %
7.92%
Top 10 Hldgs %
29.35%
Holding
15,428
New
1,885
Increased
5,794
Reduced
5,768
Closed
1,724

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.26B
2
MSFT icon
Microsoft
MSFT
+$633M
3
BABA icon
Alibaba
BABA
+$501M
4
ATVI
Activision Blizzard
ATVI
+$484M
5
AAPL icon
Apple
AAPL
+$456M

Sector Composition

Rank Sector Weight
1 Technology 3.08%
2 Consumer Discretionary 2.25%
3 Financials 2.23%
4 Healthcare 2.22%
5 Industrials 1.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGZ icon
13626
iShares Agency Bond ETF
AGZ
$565M
-45,680
Closed -$5.41M
AIRI icon
13627
Air Industries Group
AIRI
$12.3M
-5,493
Closed -$71K
AIZ icon
13628
Assurant
AIZ
$13.9B
-3,941
Closed -$636K
CHGA
13629
Change Agents Corporation Common Stock
CHGA
$2.8M
-211
Closed -$31K
ALEX
13630
DELISTED
Alexander & Baldwin
ALEX
-13,499
Closed -$277K
ALHC icon
13631
CALL
Alignment Healthcare
ALHC
$2.9B
-33,100
Closed -$774K
ALHC icon
13632
PUT
Alignment Healthcare
ALHC
$2.9B
-11,100
Closed -$259K
ALGS icon
13633
Aligos Therapeutics
ALGS
$43M
-654
Closed -$334K
AMBO
13634
Ambow Education Holding
AMBO
$6.09M
-1,200
Closed -$29K
AMCR icon
13635
PUT
Amcor
AMCR
$21.3B
-3,360
Closed -$193K
AMPH icon
13636
Amphastar Pharmaceuticals
AMPH
$889M
-24,373
Closed -$492K
AMS icon
13637
American Shared Hospital Services
AMS
$9.94M
-30,398
Closed -$89K
ANAB icon
13638
PUT
AnaptysBio
ANAB
$1.73B
-8,300
Closed -$215K
ANGL icon
13639
CALL
VanEck Fallen Angel High Yield Bond ETF
ANGL
$3.11B
-13,400
Closed -$441K
ANIK icon
13640
CALL
Anika Therapeutics
ANIK
$288M
-6,700
Closed -$290K
YDKG
13641
PUT
Yueda Digital Holding
YDKG
$5.92M
-36
Closed -$42K
AOM icon
13642
iShares Core Moderate Allocation ETF
AOM
$1.78B
-22,132
Closed -$997K
AOR icon
13643
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.75B
-43,359
Closed -$2.43M
AP icon
13644
CALL
Ampco-Pittsburgh
AP
$194M
-16,900
Closed -$103K
APH icon
13645
Amphenol
APH
$206B
-841,700
Closed -$30.9M
API
13646
Agora
API
$392M
-89,077
Closed -$2.78M
APLT
13647
DELISTED
Applied Therapeutics
APLT
-13,119
Closed -$227K
APM
13648
DELISTED
Aptorum Group
APM
-1,091
Closed -$35K
APOG icon
13649
CALL
Apogee Enterprises
APOG
$889M
-9,500
Closed -$387K
ARAY icon
13650
CALL
Accuray
ARAY
$33.2M
-24,100
Closed -$109K

Similar funds

Ken Griffin's Q3 2021 Portfolio in Review

As of Q3 2021, Ken Griffin held 15,428 positions worth $481B, up 7.8% from $447B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Ken Griffin deployed $38.1B of net new capital in Q3 2021, opening 1,885 new positions and adding to 5,794 existing holdings. Its largest new stake was Etsy: 948,509 shares worth $197M.

By sector, the portfolio is most concentrated in Technology at 3.1% of assets, down from 3.2% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $622M trimmed.

  • Ken Griffin's largest Q3 2021 buy was Etsy: 948,509 shares worth $197M.
  • Ken Griffin added most to Tesla in Q3 2021, an estimated $1.26B increase.
  • Ken Griffin's biggest Q3 2021 reduction was Meta Platforms (Facebook), cutting an estimated $622M.
  • Ken Griffin fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $597M.
  • Ken Griffin's ten largest holdings make up 29% of its $481B portfolio in Q3 2021.
  • Ken Griffin opened 1,885 new positions and closed 1,724 in Q3 2021.
  • Ken Griffin's portfolio value rose 7.8% quarter-over-quarter to $481B.

Based on Citadel Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.